价格

human nerve growth factor

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
EP 2364728 A1申请人: AMGEN INC优先权: 2004
EP
US
10 件公开
Methods of preventing inflammation and treating pain using anti-NGF compositions
- US 9783601 B2
  申请人: GARCIA-MARTINEZ LEON F优先权: 2011
  US
  8 件公开
- US 9539324 B2
  申请人: ALDERBIO HOLDINGS LLC优先权: 2013
  US
  3 件公开
STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES
EP 3881867 A1申请人: REGENERON PHARMA优先权: 2010
EP
US
WO
6 件公开
Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction
US 7887792 B2申请人: UNIV PITTSBURGH优先权: 2005
US
6 件公开
High affinity human antibodies to human nerve growth factor
US 7988967 B2申请人: REGENERON PHARMA优先权: 2008
US
6 件公开
PRODUCTION OF NERVE GROWTH FACTOR (NGF) AND OF MUTEINS THEREOF
US 2021079053 A1申请人: CHIESI FARM SPA优先权: 2018
EP
US
WO
5 件公开
Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
US 8642552 B2申请人: FERNANDEZ MONTEQUIN JOSE IGNACIO优先权: 2006
CN
US
5 件公开
Methods of treating conditions caused by increased expression of nerve growth factor (NGF) or increased sensitivity to NGF using anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
US 9260514 B2申请人: WILD JR KENNETH D优先权: 2009
CN
EP
US
4 件公开
Specific binding members for NGF
US 9315571 B2申请人: FRANKS RUTH优先权: 2006
CN
US
4 件公开
Methods of preventing or treating pain using anti-NGF antibodies
US 9067988 B2申请人: ALDERBIO HOLDINGS LLC优先权: 2013
US
4 件公开

药物

human nerve growth factor

专利

Methods of preventing inflammation and treating pain using anti-NGF compositions